Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Camp4 Therapeutics Corp (CAMP)

Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Camp4 Therapeutics Corp ONE KENDALL SQUARE BUILDING 1400 WEST 3RD FLOOR CAMBRIDGE MA 02139 USA

www.camp4tx.com Employees: 55 P: 617-651-8867

Sector:

Medical

Description:

CAMP4 Therapeutics Corporation is a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases. CAMP4 Therapeutics Corporation is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 304,258
Enterprise Value, $K 240,218
Shares Outstanding, K 46,881
Annual Sales, $ 650 K
Annual Net Income, $ -51,790 K
Last Quarter Sales, $ 800 K
Last Quarter Net Income, $ -15,100 K
EBIT, $ -54,470 K
EBITDA, $ -52,770 K
60-Month Beta 1.28
% of Insider Shareholders 33.60%
% of Institutional Shareholders 0.00%
Float, K 31,129
% Float 66.40%
Short Volume Ratio 0.16

Growth:

1-Year Return -26.91%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 11/06/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -1.79
EPS Growth vs. Prev Qtr 11.29%
EPS Growth vs. Prev Year 97.73%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CAMP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -100.10%
Return-on-Assets % -76.62%
Profit Margin % -7,967.69%
Debt/Equity 0.00
Price/Sales 432.14
Price/Cash Flow N/A
Price/Book 4.57
Book Value/Share 1.25
Interest Coverage -2.47
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar